SCHEMBL10127459

SCHEMBL10127459

c1ccc(-c2ccc3c4ccccc4n4c(-c5ccc(-c6cccc7c6sc6ccccc67)cc5)nnc4c3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
ALOX5 P09917 1/20 0.42
PRKDC P78527 2/20 0.36
TYMS P04818 1/20 0.35
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 2/20 0.34
MAPT P10636 2/20 0.34
G6PD P11413 1/20 0.34
PKM P14618 1/20 0.34
ALOX12 P18054 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LIMK1 P53667 2/20 0.33
PARP14 Q460N5 1/20 0.33
MAOA P21397 2/20 0.33
PIM3 Q86V86 1/20 0.33
F9 P00740 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128378 0.93 ALOX5 (0.43) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10127448 0.93 ALOX5 (0.43) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10127470 0.93 ALOX5 (0.43) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL515975 0.93 ALOX5 (0.43) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10128406 0.93 ALOX5 (0.43) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10127472 0.92 ALOX5 (0.42) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10127329 0.92 POLB (0.47) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10127327 0.92 POLB (0.46) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL515618 0.90 POLB (0.46) POLBALOX5PRKDCTYMSALDH1A1
SCHEMBL10128383 0.90 POLB (0.43) POLBALOX5PRKDCTYMSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 POLB 3317/4885ALOX5 1457/4885PRKDC 2900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.